Kan. Admin. Regs. § 65-4-1 - Definitions

For the purpose of these rules and regulations the following terms shall have the meanings respectively ascribed to them.

(a) "Advertising" means all representations disseminated in any manner or by any means, for the purpose of inducing, or which are likely to induce, directly or indirectly, the purchase of professional services or ophthalmic goods.
(b) "Biomicroscopy" means evaluation of the exterior and interior segments of the eye under highly magnified conditions by use of a bio-microscope.
(c) "Board" means the Kansas board of examiners in optometry.
(d) "Contact lens adaptation" means the period of time from the initial dispensing of contact lenses until a licensee exercising professional judgment determines by follow-up visits that the patient has achieved an acceptable level of wearing time with no indication of eye health-or vision-related problems.
(e) "Contact lens evaluation" means measurement of the anatomical and physiological characteristics of the eyes and lids for designing or determining the fit and effect on the eyes and lids of a therapeutic or cosmetic contact lens, including a plano contact lens.
(f) "Coordination testing" means subjective and objective far and nearpoint balance test for the investigation of the binocular functions of accommodation and convergence.
(g) "External examination" means objective evaluation of the globe (cornea, aqueous, iris, pupil, conjunctiva), the lids, cilia and lacrimation by use of magnification instruments as required by the licensee.
(h) "License" means a license to practice optometry granted pursuant to the optometry law.
(i) "Licensee" means a person licensed pursuant to the optometry law to practice optometry.
(j) "Medical facility" shall have the meaning ascribed to that term in subsection (c) of K.S.A. 65-411 and amendments thereto.
(k) "Medical care facility" shall have the meaning ascribed to that term in K.S.A. 65-425 and amendments thereto.
(l) "National board examination" means all parts of the examination being then administered by the national board of examiners in optometry and any examination then being administered by the international association of boards on treatment and management of ocular disease.
(m) "Office or practice location" means that address, building, or location, including each location of a mobile facility, where any optometric services or the practice acts are performed and from which a licensee has, maintains, or derives a financial benefit or interest either directly or indirectly.
(n) "Ophthalmic goods" means any goods which are used, sold or supplied in conjunction with or as a result of optometric services including, but not limited to:
(1) spectacles;
(2) any component of spectacles;
(3) contact lenses; and
(4) any care products associated with contact lenses.
(o) "Ophthalmic lenses" means any type of spectacle or contact lenses.
(p) "Ophthalmoscopy" means evaluating the interior anatomy of the eye with a selfilluminated magnifying instrument such as an ophthalmo-scope.
(q) "Optometric services" means those acts which constitute the practice of optometry as defined in K.S.A. 65-1501.
(r) "Orthoptic or visual training evaluation" means measuring the sensory, motor, and intersensory functions related to visual perception and coordination of the two eyes for efficient binocular vision by using instrumentation for measuring deviations of visual axes alignment, retinal correspondence, foveal integrity, perception, form and visual memory testing.
(s) "Person" means an individual, association, partnership, corporation or other entity.
(t) "Prescription" means a verbal or written order from a licensee which designates either the specifications and directions for lenses, prisms, orthoptic exercises or visual training therapy to be used for the aid of any insufficiencies or abnormal conditions of the eyes.
(u) "Prescription for topical pharmaceutical drugs" means a verbal or written order, directly from a licensee expressly certified to prescribe drugs pursuant to the optometry law, authorizing the purchase or use of topical pharmaceutical drugs.
(v) "Refraction" means the determination of the spherical and cylindrical lens powers required for each eye to achieve the state of emmetropia at a specified distance by use of appropriate instruments capable of producing reliable findings.
(w) "Topical pharmaceutical drugs" means drugs administered topically and not by other means for the examination, diagnosis and treatment of the human eye and its adnexae including:
(1) anesthetics;
(2) mydriatics;
(3) cycloplegics;
(4) anti-infectives; and
(5) anti-inflammatory agents limited to a fourteen day supply.
(x) "Tonometry" means the measurement of the intraocular pressure by use of an indentation, applanation, or non-contact type of tonometer, capable of producing reliable findings.

Notes

Kan. Admin. Regs. § 65-4-1
Authorized by K.S.A. 74-1504(a)(6); implementing K.S.A. 65-1501, K.S.A. 65-1501a, K.S.A. 1991 Supp. 65-1502, K.S.A. 65-1504b and K.S.A. 65-1506; effective May 18, 1992.

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.